Oncolytics Biotech, Inc.
ONCY
Get informed when a big investor buys or sells
+ FollowMarket Cap$80.54M
Close$
$0.05
94% downside
Current Fair Value
94% downsideOvervalued by 94% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $80.54 Million |
|---|---|
| Enterprise Value | $75.55 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.41 |
| Beta | 1.1 |
| Outstanding Shares | 112,292,579 |
Return
| Return on Equity | 610.43% |
|---|---|
| Return on Assets | -383.72% |
| Return on Invested Capital | -1135.03% |
Valuation & Multiples
| P/E Ratio | -3.32 |
|---|---|
| PEG | -8.69 |
| Price to Sales | - |
| Price to Book Ratio | -0.8 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -2.43 |
| Enterprise Value to Net Income | -3 |
| Total Debt to Enterprise | 0.01 |
| Debt to Equity | -0.1 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 12, 2026
EPS Estimate
$-0.05
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationNext Earnings Call
Expected Date
August 14, 2026
EPS Estimate
$-0.05
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 0.89%▼ 1.78% |
|---|---|
| Total Invested | $939,090▼ 63.96% |
| Investors Holding | 32▼ 25.00% |
ESG Score
No data